The intra- tumor heterogeneity observed in both primary and metastatic sites, with significantly higher PD-L1 expression in metastatic sites, indicates that a single core biopsy might not be sufficient to determine PD-L1 expression. The gene discussed is CD274; the disease is neoplasm.